Literature DB >> 29651761

Computer-Based Readability Testing of Information Booklets for German Cancer Patients.

Christian Keinki1, Richard Zowalla2, Monika Pobiruchin3, Jutta Huebner4, Martin Wiesner2.   

Abstract

Understandable health information is essential for treatment adherence and improved health outcomes. For readability testing, several instruments analyze the complexity of sentence structures, e.g., Flesch-Reading Ease (FRE) or Vienna-Formula (WSTF). Moreover, the vocabulary is of high relevance for readers. The aim of this study is to investigate the agreement of sentence structure and vocabulary-based (SVM) instruments. A total of 52 freely available German patient information booklets on cancer were collected from the Internet. The mean understandability level L was computed for 51 booklets. The resulting values of FRE, WSTF, and SVM were assessed pairwise for agreement with Bland-Altman plots and two-sided, paired t tests. For the pairwise comparison, the mean L values are LFRE = 6.81, LWSTF = 7.39, LSVM = 5.09. The sentence structure-based metrics gave significantly different scores (P < 0.001) for all assessed booklets, confirmed by the Bland-Altman analysis. The study findings suggest that vocabulary-based instruments cannot be interchanged with FRE/WSTF. However, both analytical aspects should be considered and checked by authors to linguistically refine texts with respect to the individual target group. Authors of health information can be supported by automated readability analysis. Health professionals can benefit by direct booklet comparisons allowing for time-effective selection of suitable booklets for patients.

Entities:  

Keywords:  Evidence-based health information; Patient information booklets; Readability; Support vector machine; Understandability

Year:  2019        PMID: 29651761     DOI: 10.1007/s13187-018-1358-0

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  21 in total

Review 1.  Measuring agreement in method comparison studies.

Authors:  J M Bland; D G Altman
Journal:  Stat Methods Med Res       Date:  1999-06       Impact factor: 3.021

2.  Suitability of prostate cancer education materials: applying a standardized assessment tool to currently available materials.

Authors:  Debra Weintraub; Sally L Maliski; Arlene Fink; Sarah Choe; Mark S Litwin
Journal:  Patient Educ Couns       Date:  2004-11

Review 3.  A systematic review of readability and comprehension instruments used for print and web-based cancer information.

Authors:  Daniela B Friedman; Laurie Hoffman-Goetz
Journal:  Health Educ Behav       Date:  2006-06

4.  Effectiveness of strategies for informing, educating, and involving patients.

Authors:  Angela Coulter; Jo Ellins
Journal:  BMJ       Date:  2007-07-07

5.  A new readability yardstick.

Authors:  R FLESCH
Journal:  J Appl Psychol       Date:  1948-06

6.  Research briefs reading grade level and readability of printed cancer education materials.

Authors:  Judy Singh
Journal:  Oncol Nurs Forum       Date:  2003 Sep-Oct       Impact factor: 2.172

Review 7.  Low health literacy and health outcomes: an updated systematic review.

Authors:  Nancy D Berkman; Stacey L Sheridan; Katrina E Donahue; David J Halpern; Karen Crotty
Journal:  Ann Intern Med       Date:  2011-07-19       Impact factor: 25.391

8.  Helping patients decide: ten steps to better risk communication.

Authors:  Angela Fagerlin; Brian J Zikmund-Fisher; Peter A Ubel
Journal:  J Natl Cancer Inst       Date:  2011-09-19       Impact factor: 13.506

9.  Addressing low literacy and health literacy in clinical oncology practice.

Authors:  Sofia F Garcia; Elizabeth A Hahn; Elizabeth A Jacobs
Journal:  J Support Oncol       Date:  2010 Mar-Apr

10.  A survey of the quality and accuracy of information leaflets about skin cancer and sun-protective behaviour available from UK general practices and community pharmacies.

Authors:  S Nicholls; M Hankins; C Hooley; H Smith
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-01-21       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.